The high price of brand-name GLP-1 medications is one of the biggest challenges for patients seeking obesity treatment (BMI 30 or more), overweight (BMI 27 or more), and type 2 diabetes mellitus
What Clinical Evidence Shows About Safety in Heart Patients The LEADER trial (2016) and SUSTAIN-6 trial (2017) enrolled thousands of diabetic patients with pre-existing cardiovascular disease and found semaglutide reduced the composite outcome of cardiovascular death, non-fatal heart attack, and non-fatal stroke
The pureec original Gold can be sold individually
Form Healths physicians will have full discretion over who they prescribe the medications to, or if a weight loss drug is the right fit for a patient
The self-insured part of the employer market is more likely to cover GLP-1s, since employers may feel pressure to cover the medications, and because the tenure of workers is generally longer in larger self-insured companies
Now, we recognize it as a powerful weight loss medication that can help people from all walks of life reach their health and aesthetic goals
